Fortis Healthcare Limited — Board Meeting, 20-05-2025: Outcome of Board Meeting

Fortis Healthcare has announced a board meeting on May 20, 2025, approving the audited consolidated financial results for the quarter and year ended March 31, 2025. Revenue rose 13% YoY to ₹7,782.75 Cr, with net profit up 25.5% at ₹809.38 Cr. EBITDA jumped to ₹1,654.88 Cr, led by strong healthcare and diagnostics growth. The board approved a final dividend of ₹1 per share. Strategic moves include acquiring non-controlling stakes in Agilus Diagnostics for ₹1,777.74 Cr, partly funded by ₹1,550 Cr non-convertible debentures, and selling Arcot Road and Richmond Road hospitals. Secretarial and cost auditors were appointed for FY2025-26.